secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001493152-23-019455
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience receives Nasdaq delisting notice for failure to meet $2.5M equity minimum
--------------------------------------------------------------------------------

- Nasdaq notified INVO on May 23, 2023, of non-compliance with Listing Rule 5550(b)(1) requiring $2.5M stockholders' equity.
- Company failed to regain compliance by the May 22, 2023 extension deadline.
- INVO plans to request a hearing before the Nasdaq Hearings Panel to stay delisting.
- No assurance that the Panel will grant continued listing or an extension.
- Stockholders' equity deficiency triggers potential delisting from Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223019455/0001493152-23-019455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223019455/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer